Contract Pharmaceuticals Limited Canada
⚠️ High Risk
FEI: 3001581899 • Mississauga, Ontario • CANADA
FEI Number
3001581899
Location
Mississauga, Ontario
Country
CANADAAddress
7600 East Danbro Cres, , Mississauga, Ontario, Canada
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 3/29/2024 | 66VCY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/29/2024 | 66VCY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 1/3/2014 | 62LBO52PERMETHRIN (ANTI-PROTOZOAL, A-LEISHMANIAL, ANTI-MALARIAL) | 118NOT LISTED | New Orleans District Office (NOL-DO) |
| 1/3/2014 | 62LBO52PERMETHRIN (ANTI-PROTOZOAL, A-LEISHMANIAL, ANTI-MALARIAL) | 118NOT LISTED | New Orleans District Office (NOL-DO) |
| 8/16/2012 | 61HDJ45SODIUM SULFACETAMIDE (ANTI-BACTERIAL, PART III) | 75UNAPPROVED | Detroit District Office (DET-DO) |
| 3/8/2012 | 61HDL45SODIUM SULFACETAMIDE (ANTI-BACTERIAL, PART III) | 75UNAPPROVED | Detroit District Office (DET-DO) |
| 2/13/2012 | 61HDL45SODIUM SULFACETAMIDE (ANTI-BACTERIAL, PART III) | 75UNAPPROVED | Detroit District Office (DET-DO) |
| 5/2/2011 | 66YAY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C. | New York District Office (NYK-DO) | |
| 5/2/2011 | 66YAY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C. | New York District Office (NYK-DO) | |
| 9/14/2010 | 66VIP99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
Frequently Asked Questions
What is Contract Pharmaceuticals Limited Canada's FDA import refusal history?
Contract Pharmaceuticals Limited Canada (FEI: 3001581899) has 10 FDA import refusal record(s) in our database, spanning from 9/14/2010 to 3/29/2024.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Contract Pharmaceuticals Limited Canada's FEI number is 3001581899.
What types of violations has Contract Pharmaceuticals Limited Canada received?
Contract Pharmaceuticals Limited Canada has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Contract Pharmaceuticals Limited Canada come from?
All FDA import refusal data for Contract Pharmaceuticals Limited Canada is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.